TOLEDO

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations

Topic / Pathology

  • Parkinson's Disease

Objectives

To have more informations, click on the link below: 

https://clinicaltrials.gov/ct2/show/NCT02006121?term=toledo&cond=parkinson&cntry=FR&draw=2&rank=1

Sponsor

Britannia Pharmaceuticals Ltd.

Scientific publication(s)

  • Katzenschlager R et al. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2018 Sep;17(9):749-759. 

    https://pubmed.ncbi.nlm.nih.gov/30055903/

Status

Published results

Participating centers

Share

Updated on 17 February 2023